Literature DB >> 9014205

Tuberculosis in Africa: clinical presentation and management.

A D Harries1.   

Abstract

In the last decade, sub-Saharan Africa has experienced an explosive increase in tuberculosis (TB) cases, largely as a result of the co-epidemic of human immunodeficiency virus (HIV) infection. This article reviews the essential background epidemiology of TB in sub-Saharan Africa. The clinical features and diagnostic problems of pulmonary/extrapulmonary TB in adults and children are discussed, particularly in relation to HIV infection. Different treatment regimens, their cost, adverse reactions, the ways in which HIV infection influences treatment response and the extent of drug resistance are reviewed. The recommended approaches to TB control in Africa, including methods used to prevent TB through Bacillus Calmette-Guerin and chemoprophylaxis are examined. The success achieved by good National TB Control Programmes in some African countries allows cautious optimism that this epidemic can be controlled.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9014205     DOI: 10.1016/s0163-7258(96)00115-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  9 in total

1.  Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi.

Authors:  Thomas K Hartung; Daniel Chimbayo; Joep J G van Oosterhout; Tarsizio Chikaonda; Gerard J J van Doornum; Eric C J Claas; Willem J G Melchers; Malcolm E Molyneux; Ed E Zijlstra
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Cryptococcosis and tuberculosis co-infection at a university hospital in Taiwan, 1993-2006.

Authors:  C-T Huang; Y-J Tsai; J-Y Fan; S-C Ku; C-J Yu
Journal:  Infection       Date:  2010-07-27       Impact factor: 3.553

3.  mosR, a novel transcriptional regulator of hypoxia and virulence in Mycobacterium tuberculosis.

Authors:  Bassam Abomoelak; Elizabeth A Hoye; Jing Chi; Sarah A Marcus; Francoise Laval; John P Bannantine; Sarah K Ward; Mamadou Daffé; Hong Di Liu; Adel M Talaat
Journal:  J Bacteriol       Date:  2009-07-31       Impact factor: 3.490

4.  Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre.

Authors:  D K Lewis; Rph Peters; M J Schijffelen; Grf Joaki; A L Walsh; J G Kublin; J Kumwenda; S Kampondeni; M E Molyneux; E E Zijlstra
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

5.  Imaging of tuberculosis of the abdominal viscera: beyond the intestines.

Authors:  Saurabh Karmakar; Alok Nath; Hira Lal
Journal:  J Clin Imaging Sci       Date:  2013-09-30

6.  Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia.

Authors:  Edford Sinkala; Sylvia Gray; Isaac Zulu; Victor Mudenda; Lameck Zimba; Sten H Vermund; Francis Drobniewski; Paul Kelly
Journal:  BMC Infect Dis       Date:  2009-04-17       Impact factor: 3.090

7.  Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival.

Authors:  Stephen B Gordon; Mas Chaponda; Amanda L Walsh; Christopher J M Whitty; Melita A Gordon; C Edward Machili; Charles F Gilks; Martin J Boeree; Sam Kampondeni; Robert C Read; Malcolm E Molyneux
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

8.  Patient outcome in adults with pneumococcal meningitis or bacteraemia admitted to QECH.

Authors:  Stephen B Gordon
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

9.  Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.

Authors:  Colleen F Hanrahan; Katerina Selibas; Christopher B Deery; Heather Dansey; Kate Clouse; Jean Bassett; Lesley Scott; Wendy Stevens; Ian Sanne; Annelies Van Rie
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.